Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Conferences
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Bioentrepreneur
Nature Reviews Drug Discovery
Nature
Nature Medicine
Nature Genetics
Nature Reviews Genetics
Nature Methods
Nature Chemical Biology
news@nature.com
Clinical Pharmacology & Therapeutics
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Biotechnology  19, 958 - 961 (2001)
doi:10.1038/nbt1001-958

Designing a polyvalent inhibitor of anthrax toxin

Michael Mourez1, Ravi S. Kane2, Jeremy Mogridge1, Steve Metallo2, Pascal Deschatelets2, Bret R. Sellman1, George M. Whitesides2 & R. John Collier1

1  Department of Microbiology and Molecular Genetics, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115.

2  Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, MA 02138.

Correspondence should be addressed to R. John Collier jcollier@hms.harvard.edu
Screening peptide libraries is a proven strategy for identifying inhibitors of protein−ligand interactions. Compounds identified in these screens often bind to their targets with low affinities. When the target protein is present at a high density on the surface of cells or other biological surfaces, it is sometimes possible to increase the biological activity of a weakly binding ligand by presenting multiple copies of it on the same molecule. We isolated a peptide from a phage display library that binds weakly to the heptameric cell-binding subunit of anthrax toxin and prevents the interaction between cell-binding and enzymatic moieties. A molecule consisting of multiple copies of this nonnatural peptide, covalently linked to a flexible backbone, prevented assembly of the toxin complex in vitro and blocked toxin action in an animal model. This result demonstrates that protein−protein interactions can be inhibited by a synthetic, polymeric, polyvalent inhibitor in vivo.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REVIEWS
Innovation: Virtual screening using grid computing: the screensaver project
Nature Reviews Drug Discovery Perspective (01 Jul 2002)

NEWS AND VIEWS
A dominant-negative therapy for anthrax
Nature Medicine News and Views (01 Jun 2001)
Anthrax delivers a lethal blow to host immunity
Nature Medicine News and Views (01 Aug 2003)

RESEARCH
Identification of the cellular receptor for anthrax toxin
Nature Letters to Editor (08 Nov 2001)
Identification of small molecule inhibitors of anthrax lethal factor
Nature Structural & Molecular Biology Article (01 Jan 2004)

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

Figures & Tables
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Biotechnology
ISSN: 1087-0156
EISSN: 1546-1696
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | Conferences | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2001 Nature Publishing Group | Privacy policy